secwatch.observer — SEC 8-K summary
======================================

Issuer:     SS Innovations International, Inc. (SSII)
CIK:        0001676163
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001213900-26-036006
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SSi Mantra approved in Colombia, Oman, Sri Lanka, Kenya; total approvals now 11 countries
--------------------------------------------------------------------------------

- Regulatory approvals from INVIMA (Colombia, Nov 2025), DGPA&DC (Oman, Nov 2025), NMRA (Sri Lanka, Jan 2026), and PPB (Kenya, Jan 2026).
- Cumulative installed base of SSi Mantra reached 168 systems across 10 countries as of Dec 31, 2025.
- Cumulative surgeries total 7,885 including 390 cardiac and 121 pediatric; over 150 telesurgeries performed.
- Company anticipates FDA 510(k) decision by mid-2026 and CE marking in 2026 for SSi Mantra.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026036006/0001213900-26-036006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676163/000121390026036006/ea0283970-8k_ssinnova.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-036006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer